Stock INM INMED PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart InMed Pharmaceuticals Inc.

Equities

INM

CA4576376012

Delayed Nasdaq
Other stock markets
 01:31:03 2024-06-05 pm EDT 		5-day change 1st Jan Change
0.3002 USD +3.55% Intraday chart for InMed Pharmaceuticals Inc. +7.21% -27.84%
May. 14 Earnings Flash (INM) INMED PHARMACEUTICALS Posts Q3 Revenue $1.2M MT
May. 14 InMed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
INMED PHARMACEUTICALS INC. Stock InMed Pharmaceuticals Inc.
 1.84M - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 123B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.01B -
ARGENX SE Stock argenx SE
 22.59B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. INM Stock
  4. Charts InMed Pharmaceuticals Inc.
  5. Sector Chart